An enhanced antioxidant strategy of astaxanthin encapsulated in ROS-responsive nanoparticles for combating cisplatin-induced ototoxicity
Abstract Background Excessive accumulation of reactive oxygen species (ROS) has been documented as the crucial cellular mechanism of cisplatin-induced ototoxicity. However, numerous antioxidants have failed in clinical studies partly due to inefficient drug delivery to the cochlea. A drug delivery s...
Main Authors: | Jiayi Gu, Xueling Wang, Yuming Chen, Ke Xu, Dehong Yu, Hao Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-06-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-022-01485-8 |
Similar Items
-
Current Strategies to Combat Cisplatin-Induced Ototoxicity
by: Dehong Yu, et al.
Published: (2020-07-01) -
Astaxanthine attenuates cisplatin ototoxicity in vitro and protects against cisplatin-induced hearing loss in vivo
by: Benyu Nan, et al.
Published: (2022-01-01) -
Astaxanthin-loaded polymer-lipid hybrid nanoparticles (ATX-LPN): assessment of potential otoprotective effects
by: Jiayi Gu, et al.
Published: (2020-03-01) -
Cisplatin ototoxicity histopathology
by: Sarah E. Hodge, et al.
Published: (2021-08-01) -
The protective effect of coumaric acid against cisplatin-induced ototoxicity in rats
by: Fazile Nur Ekinci Akdemir, et al.
Published: (2018-06-01)